Medication info
Lapuzone Tablets (Lafutidine)

Lapuzone Tablets (Lafutidine)

Prescription medicationTabletOral
Ingredient · strength
Lafutidine›10mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201302942 · Approved 2013.01.31 · Insurance code 671805490

Summary

Main use
Treatment of gastrointestinal disorders (ulcers, gastritis, etc.), pre-anesthetic medication, and combination therapy for eradication
Who takes it
Adults
Adult dose
1. Short-term treatment of gastric ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was given for up to 8 weeks, most ulcers healed within 8 weeks; however, healing time may occasionally vary from patient to patient. 2. Short-term treatment of duodenal ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was given for up to 6 weeks, most ulcers healed within 6 weeks; however, healing time may occasionally vary from patient to patient. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose is 10mg of lafutidine orally once daily before bedtime. In clinical trials in which treatment was given for up to 2 weeks, most lesions healed within 2 weeks; however, healing time may occasionally vary from patient to patient. 4. Concomitant antibiotic therapy in patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 days or 14 days. 5. Premedication before anesthesia: The usual dose is 10mg of lafutidine per dose, administered orally twice (before bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer 10mg of lafutidine per dose twice daily.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (ulcers, gastritis, etc.), pre-anesthetic medication, and combination therapy for eradication

  • Gastric ulcer
  • duodenal ulcer
  • gastric mucosal lesions due to acute gastritis
  • chronic gastritis
  • peptic ulcer
  • gastroesophageal reflux disease
View approved original text

This medication is used for the treatment of gastric ulcers and duodenal ulcers. It also helps improve gastric mucosal damage caused by acute gastritis and chronic gastritis. It is used in combination with antibiotics when treating peptic ulcers in patients infected with Helicobacter pylori. It is given before surgery to control gastric acid secretion and is effective in treating gastroesophageal reflux disease. Thus, it is used to alleviate and treat symptoms of various gastrointestinal disorders.

How to take

Adult dose

1. Short-term treatment of gastric ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was given for up to 8 weeks, most ulcers healed within 8 weeks; however, healing time may occasionally vary from patient to patient. 2. Short-term treatment of duodenal ulcers: The usual dose is 10mg of lafutidine orally twice daily, in the morning and before bedtime. In clinical trials in which treatment was given for up to 6 weeks, most ulcers healed within 6 weeks; however, healing time may occasionally vary from patient to patient. 3. Improvement of gastric mucosal lesions in acute and chronic gastritis: The usual dose is 10mg of lafutidine orally once daily before bedtime. In clinical trials in which treatment was given for up to 2 weeks, most lesions healed within 2 weeks; however, healing time may occasionally vary from patient to patient. 4. Concomitant antibiotic therapy in patients with peptic ulcers infected with Helicobacter pylori: Administer lafutidine 20mg, clarithromycin 500mg, and amoxicillin 1000mg twice daily for 7 days or 14 days. 5. Premedication before anesthesia: The usual dose is 10mg of lafutidine per dose, administered orally twice (before bedtime on the day before surgery and 2 hours before anesthesia on the day of surgery). 6. Treatment of reflux esophagitis: Administer 10mg of lafutidine per dose twice daily.

Precautions

This medication should not be used in patients with known allergies to any component of this product. It contains lactose, so it should not be used in patients with genetic lactose intolerance, lactase deficiency, or glucose-galactose malabsorption. Caution should be exercised when administering to patients with a history of allergies, liver or kidney function problems, patients undergoing dialysis, and the elderly. Rarely, severe allergic reactions or shocks may occur, and if symptoms such as pallor, low blood pressure, or difficulty breathing appear, the medication should be stopped immediately, and medical attention should be sought. Liver function abnormalities may occur, leading to elevated liver enzymes and symptoms of jaundice, so regular liver function tests are necessary, and if abnormalities are found, the medication should be discontinued. Blood cell abnormalities may occur, and if symptoms like sore throat, fatigue, or fever appear, the patient should consult a physician immediately. Rare cases of serious side effects such as skin rash, convulsions, and cardiac rhythm disturbances have been reported, necessitating immediate consultation with medical personnel in case of abnormal symptoms. Gastrointestinal symptoms may include constipation, diarrhea, nausea, vomiting, abdominal distension, and loss of appetite. Central nervous system symptoms may include headaches, insomnia, drowsiness, and dizziness. Regular blood tests are necessary as white blood cell or red blood cell counts may vary. The elderly should be administered with caution, adjusting doses and intervals due to decreased physical function. Patients undergoing dialysis may have increased blood drug concentrations, hence treatment should start at a low dose. Pregnant women should use this medication only if the benefits outweigh the risks, as determined by a physician, and breastfeeding women should avoid its use since it may be secreted in breast milk. Safety in pediatric patients has not been sufficiently established, thus caution is required in use. Keep out of reach of children, and do not transfer the medication from its original container to another container. This medication may alleviate symptoms of malignancy or delay diagnosis; therefore, if a malignancy is suspected in gastric ulcer patients, evaluation should be carried out, and if malignant gastric cancer is confirmed, the medication should be discontinued. During treatment, it is essential to closely monitor the condition of the disease and use it for only the necessary minimum period.

Side effects

  • Shock
  • anaphylaxis symptoms
  • facial pallor
  • hypotension
  • generalized rash
  • dyspnea
  • liver dysfunction
  • jaundice
  • agranulocytosis
  • pharyngalgia
Show 81 more
  • generalized malaise
  • fever
  • thrombocytopenia
  • pancytopenia
  • aplastic anemia
  • seizures
  • interstitial nephritis
  • Stevens-Johnson syndrome
  • Reye's syndrome
  • rhabdomyolysis
  • heart block
  • systolic dysfunction
  • constipation
  • diarrhea
  • hard stools
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • headache
  • insomnia
  • drowsiness
  • reversible confusional state
  • hallucinations
  • consciousness disturbance
  • dizziness
  • chills
  • heat sensation
  • facial flushing
  • leukocytosis
  • eosinophilia
  • leukopenia
  • erythrocytopenia
  • decreased hematocrit
  • elevated ALT
  • elevated AST
  • elevated Al-P
  • elevated γ-GTP
  • elevated T-Bil
  • elevated LDH
  • elevated TTT
  • abnormal urine protein
  • elevated BUN
  • elevated serum uric acid
  • elevated Cl
  • delayed maturation
  • elevated Na
  • decreased K
  • gynecomastia
  • edema
  • malaise
  • glossitis
  • headache
  • urticaria
  • skin rash
  • abdominal pain
  • dyspepsia
  • enteritis
  • gastric ulcer
  • erosive gastritis
  • duodenitis
  • bloating
  • nasopharyngitis
  • upper respiratory infection
  • bronchopneumonia
  • tinea
  • carotid artery stenosis
  • cough
  • oropharyngeal pain
  • oropharyngeal discomfort
  • productive cough
  • fatigue
  • chest pain
  • limb pain
  • arthralgia
  • cervical pain
  • pruritus
  • acne
  • contusion
  • insomnia
  • non-alcoholic fatty liver disease

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and humidity, so it should be stored in a tightly sealed container. A storage temperature between 1 and 30 degrees Celsius at room temperature is recommended. This will help maintain the medication's efficacy for an extended period.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.